Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4860 results found.

Example of search result explained

Sandoz Riociguat

Exceptional medication
  • Active ingredient(s):
    riociguat
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Tablet 0.5 mg DIN : 2533545
    • Tablet 1.5 mg DIN : 2533588
    • Tablet 1 mg DIN : 2533561
    • Tablet 2.5 mg DIN : 2533618
    • Tablet 2 mg DIN : 2533596

Qinlock

Exceptional medication
  • Active ingredient(s):
    ripretinib
  • Manufactured by:
    Medison Pharma Canada Inc. (Medison)
  • Strength and dosage form:
    Tablet 50 mg DIN : 2500833

Skyrizi

Exceptional medication
  • Active ingredient(s):
    risankizumab (Crohn's disease)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 60 mg/mL (10 mL) DIN : 2532107
    • S.C. Injectable Solution (mini-doser) 150 mg/mL (2,4 mL) DIN : 2532093

Skyrizi (syringe)

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 150 mg/mL (1 mL) DIN : 2519283

Skyrizi (pen)

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 150 mg/mL (1 mL) DIN : 2519291

Skyrizi

Exceptional medication
  • Active ingredient(s):
    risankizumab (plaque psoriasis)
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    Subcutaneous Injectable Solution syringe 90 mg/mL (0.83 mL) DIN : 2487454

Evrysdi

Exceptional medication
  • Active ingredient(s):
    risdiplam
  • Manufactured by:
    Hoffmann-La Roche Ltée (Roche)
  • Strength and dosage form:
    Oral Powder 60 mg (0,75 mg/mL) DIN : 2514931

Riximyo

Exceptional medication
  • Active ingredient(s):
    rituximab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    Intravenous Perfusion Solution 10 mg/mL DIN : 2498316

Ruxience

Exceptional medication
  • Active ingredient(s):
    rituximab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Intravenous Perfusion Solution 10 mg/mL DIN : 2495724

Truxima

Exceptional medication
  • Active ingredient(s):
    rituximab
  • Manufactured by:
    Teva Canada Innovation (Teva Innov)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 10 mg/mL DIN : 2478382
    • Intravenous Perfusion Solution 10 mg/mL DIN : 2478390
Page 113 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.